4
Changes in Ownership
Atea Pharmaceuticals, Inc. Filed Acc 0001567619-20-018747
Former 10% Owner acquired 6,411,355 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cormorant Asset Management, LP Former 10% Owner | 2020-11-03 | Conversion | +6,411,355 | 6,411,355 | I | ||
| Derivatives | |||||||
| Cormorant Asset Management, LP Former 10% Owner | 2020-11-03 | Conversion · Series A Convertible Preferred Stock | −1,000,000 | 0 | I | ||
| Cormorant Asset Management, LP Former 10% Owner | 2020-11-03 | Conversion · Series B Convertible Preferred Stock | −1,650,165 | 0 | I | ||
| Cormorant Asset Management, LP Former 10% Owner | 2020-11-03 | Conversion · Series C Convertible Preferred Stock | −2,631,580 | 0 | I | ||
| Cormorant Asset Management, LP Former 10% Owner | 2020-11-03 | Conversion · Series D Convertible Preferred Stock | −712,250 | 0 | I | ||
| Cormorant Asset Management, LP Former 10% Owner | 2020-11-03 | Conversion · Series D-1 Convertible Preferred Stock | −417,360 | 0 | I | ||
Loading xslF345X03/doc1.xml…